학술논문
Design of a randomized, placebo-controlled, phase 2 study evaluating the safety and efficacy of tanezumab for treatment of schwannomatosis-related pain
Document Type
Article
Author
Source
In Contemporary Clinical Trials October 2022 121
Subject
Language
ISSN
1551-7144